A detailed history of Sand Hill Global Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sand Hill Global Advisors, LLC holds 6,379 shares of ABBV stock, worth $1.26 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,379
Previous 6,521 2.18%
Holding current value
$1.26 Million
Previous $1.19 Million 7.83%
% of portfolio
0.05%
Previous 0.06%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $21,980 - $25,667
-142 Reduced 2.18%
6,379 $1.09 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $109,157 - $124,374
683 Added 11.7%
6,521 $1.19 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $41,830 - $47,110
304 Added 5.49%
5,838 $904,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $100,192 - $115,987
-750 Reduced 11.94%
5,534 $824,000
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $1.65 Million - $2.06 Million
-12,471 Reduced 66.49%
6,284 $846,000
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $9,833 - $11,324
68 Added 0.36%
18,755 $2.99 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $1.62 Million - $1.94 Million
11,711 Added 167.88%
18,687 $3.02 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $96,362 - $110,521
718 Added 11.47%
6,976 $936,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $175,603 - $223,248
1,276 Added 25.61%
6,258 $958,000
Q1 2022

May 13, 2022

SELL
$131.98 - $163.75 $108,883 - $135,093
-825 Reduced 14.21%
4,982 $808,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $136,085 - $154,477
-1,279 Reduced 18.05%
5,807 $626,000
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $77,118 - $85,914
733 Added 11.54%
7,086 $798,000
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $14,219 - $15,654
-139 Reduced 2.14%
6,353 $688,000
Q4 2020

Feb 11, 2021

SELL
$80.49 - $108.67 $18,995 - $25,646
-236 Reduced 3.51%
6,492 $695,000
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $6,443 - $7,562
75 Added 1.13%
6,728 $589,000
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $43,508 - $58,220
-593 Reduced 8.18%
6,653 $653,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $66,177 - $100,332
1,026 Added 16.5%
7,246 $552,000
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $136,325 - $170,572
1,890 Added 43.65%
6,220 $551,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $87,381 - $111,693
1,330 Added 44.33%
4,330 $315,000
Q1 2019

May 03, 2019

SELL
$77.14 - $90.79 $4,011 - $4,721
-52 Reduced 1.7%
3,000 $242,000
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $4,048 - $4,992
52 Added 1.73%
3,052 $281,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $8,891 - $9,884
-100 Reduced 3.23%
3,000 $284,000
Q2 2018

Aug 10, 2018

SELL
$89.78 - $106.23 $144,366 - $170,817
-1,608 Reduced 34.15%
3,100 $287,000
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $12,329 - $16,510
-134 Reduced 2.77%
4,708 $446,000
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $156,013 - $171,081
1,742 Added 56.19%
4,842 $468,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $216,534 - $276,582
3,100
3,100 $275,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $349B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sand Hill Global Advisors, LLC Portfolio

Follow Sand Hill Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sand Hill Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sand Hill Global Advisors, LLC with notifications on news.